Third Quarter 2022 Consolidated Financial Statements

Third Quarter 2022 MD&A

Second Quarter 2022 Consolidated Financial Statements

Second Quarter 2022 MD&A

2022 Proxy Form

2022 Management Information Circular

First Quarter 2022 MD&A

First Quarter 2022 Consolidated Financial Statements

Annual 2021 MD&A

Annual Audited Financial Statements 2021

Third Quarter 2021 Consolidated Financial Statements

Third Quarter 2021 MD&A

Second Quarter 2021 Consolidated Financial Statements

Second Quarter 2021 MD&A

2021 Management Information Circular

2021 Proxy Form

First Quarter 2021 MD&A

First Quarter 2021 Consolidated Financial Statements

Annual 2020 MD&A

Annual Audited Financial Statements 2020

2020 Form of Proxy

2020 Management Information Circular

Third Quarter 2020 MD&A

Third Quarter 2020 Consolidated Financial Statements

Second Quarter 2020 MD&A

Second Quarter 2020 Consolidated Financial Statements

First Quarter 2020 Consolidated Financial Statements

First Quarter 2020 MD&A

Annual 2019 Audited Financial Statements

Annual 2019 MD&A

Third Quarter 2019 MD&A

Third Quarter 2019 Consolidated Financial Statements

Second Quarter 2019 MD&A

Second Quarter 2019 Consolidated Financial Statements

2019 Management Proxy Circular

First Quarter 2019 MD&A

First Quarter 2019 Consolidated Financial Statements

2018 Annual Information Form

Fourth Quarter 2018 MD&A

Fourth Quarter 2018 Consolidated Financial Statements

Notice of Special Meeting of Shareholders and Information Circular

Third Quarter 2018 MD&A

Third Quarter 2018 Consolidated Financial Statements

Second Quarter 2018 MD&A

Second Quarter 2018 Consolidated Financial Statements

2018 Management Proxy Circular

First Quarter 2018 MD&A

First Quarter 2018 Consolidated Financial Statements

2017 Annual Report

2017 Annual Information Form

Fourth Quarter 2017 MD&A

Fourth Quarter 2017 Consolidated Financial Statements

Third Quarter 2017 MD&A

Third Quarter 2017 Consolidated Financial Statements

Second Quarter 2017 MD&A

Second Quarter 2017 Consolidated Financial Statements

First Quarter 2017 MD&A

First Quarter 2017 Consolidated Financial Statements

2017 Management Proxy Circular

2016 Annual Report

2016 Annual Information Form

Fourth Quarter 2016 MD&A

Full Year 2016 Consolidated Financial Statements

Third Quarter 2016 MD&A

Third Quarter 2016 Consolidated Financial Statements

Second Quarter 2016 MD&A

Second Quarter 2016 Consolidated Financial Statements

First Quarter 2016 MD&A

First Quarter 2016 Consolidated Financial Statements

2016 Management Proxy Circular

2015 Annual Report

2015 Annual Information Form

Full Year 2015 Consolidated Financial Statements

Fourth Quarter 2015 MD&A

Third Quarter 2015 Consolidated Financial Statements

Third Quarter 2015 MD&A

Second Quarter 2015 MD&A

Second Quarter 2015 Consolidated Financial Statements

First Quarter 2015 MD&A

First Quarter 2015 Consolidated Financial Statements

2015 Management Proxy Circular

2014 Annual Report

2014 Annual Information Form

Fourth Quarter 2014 MD&A

Fourth Quarter 2014 Consolidated Financial Statements

Third Quarter 2014 MD&A

Third Quarter 2014 Consolidated Financial Statements

Second Quarter 2014 MD&A

Second Quarter 2014 Consolidated Financial Statements

First Quarter 2014 MD&A

First Quarter 2014 Consolidated Financial Statements

2014 Management Proxy Circular

2013 Annual Report

2013 Annual Information Form

Fourth Quarter 2013 MD&A

Fourth Quarter 2013 Consolidated Financial Statements

Third Quarter 2013 MD&A

Third Quarter 2013 Consolidated Financial Statements

Second Quarter 2013 MD&A

Second Quarter 2013 Consolidated Financial Statements

First Quarter 2013 MD&A

First Quarter 2013 Consolidated Financial Statements

2013 Management Proxy Circular

2012 Annual Report

2012 Annual Information Form

Fourth Quarter 2012 MD&A

Fourth Quarter 2012 Consolidated Financial Statements